Printer Friendly

ISOMEDIX REPORTS RECORD FOURTH QUARTER AND RECORD YEAR END RESULTS; NET INCOME INCREASES 55 PERCENT

 WHIPPANY, N.J., Feb. 23 /PRNewswire/ -- Isomedix Inc., (NASDAQ: ISMX) today announced record sales and earnings for the fourth quarter and year ended Dec. 31, 1992.
 For the three months ended Dec. 31, Isomedix reported a 25 percent increase in consolidated sales to $9,501,200 compared with sales of $7,590,357 for the same period in 1991. Operating income increased 78 percent to $3,288,664 compared with $1,849,270 for the same period in 1991.
 Consolidated net income in the fourth quarter increased 55 percent to $2,175,355 compared with $1,401,640 earned a year ago. Based on 7,304,482 weighted average number of common shares outstanding in the fourth quarter compared with 7,127,532 shares a year ago, earnings per share were 30 cents for the fourth quarter compared with 20 cents for the same period in 1991, up 50 percent.
 Consolidated sales for the year ended Dec. 31, 1992, increased 26 percent to $36,683,273 compared with $29,027,383. Operating income increased 41 percent to $11,690,325 compared with $8,302,474 for the same period in 1991.
 Consolidated net income for the year ended Dec. 31, 1992, increased 40 percent to $7,755,398 compared with $5,531,096 earned a year ago. Based on 7,171,262 weighted average number of common shares outstanding in 1992 compared with 7,038,817 shares a year ago, earnings per share were $1.08 compared with 79 cents for the same period in 1991, up 37 percent.
 We are pleased to report increased sales in both gamma and ethylene oxide sterilization services for the quarter," said John Masefield, chairman and CEO of Isomedix. The gamma sector continued its strong growth and ethylene oxide sales increased, in part as a result of the commissioning of additional chambers in El Paso, Texas, and South Carolina.
 The expansion of the Northborough, Mass., gamma facility includes four 2,000 cubic feet EtO vessels. Construction was completed in the fourth quarter of 1992, enabling the commencement of commercial operations early in the new year.
 Isomedix Inc., based in Whippany, operates a network of nine sterilization facilities in seven states and Canada. Construction is near completion on a 10th facility in New York state, which is expected to open in early 1993. The capability to sterilize medical devices with pure ethylene oxide has now been added at three of the gamma facility locations. Isomedix also provides validation services through its Skyland Scientific Services subsidiary located in Montana.
 ISOMEDIX INC.
 Periods ended Three months Year
 Dec. 31 1992 1991 1992 1991
 Sales $9,501,200 $7,590,357 $36,683,273 $29,027,383
 Operating income 3,288,664 1,849,270 11,690,325 8,302,474
 Net income 2,175,355 1,401,640 7,755,398 5,531,096
 Earnings per share $.30 $.20 $1.08 $.79
 Weighted average
 number of shares
 outstanding 7,304,482 7,127,532 7,171,262 7,038,817
 -0- 2/23/93
 /CONTACT: Thomas J. DeAngelo, vice president-finance and administration of Isomedix Inc., 201-887-4700, or Anthony J. Russo of Noonan/Russo, 212-979-9180, for Isomedix Inc./
 (ISMX)


CO: Isomedix Inc. ST: New Jersey IN: MTC SU: ERN

CK-OS -- NY025 -- 9327 02/23/93 10:14 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 23, 1993
Words:550
Previous Article:DEERE & COMPANY REPORTS RESULTS
Next Article:MORGAN STANLEY GROUP ANNOUNCES EARNINGS
Topics:


Related Articles
INCSTAR REPORTS 55 PERCENT INCREASE IN FOURTH QUARTER EARNINGS
AMERICAN MEDICAL ELECTRONICS REPORTS THAT FOURTH QUARTER AND FULL YEAR 1991 FINANCIAL RESULTS REACH RECORD LEVELS
ISOMEDIX REPORTS SECOND QUARTER RESULTS
ISOMEDIX REPORTS RECORD SALES FOR THE THIRD QUARTER
ISOMEDIX REPORTS RECORD SALES FOR THE FOURTH QUARTER
STERIS Corporation Announces Fiscal 2005 Fourth Quarter and Full Year Results.
STERIS Corporation Announces Fiscal 2006 Fourth Quarter and Full Year Results.
STERIS Corporation Announces Fiscal 2007 Fourth Quarter and Full Year Results.
STERIS Corporation Announces Fiscal 2008 Fourth Quarter and Full Year Results.
STERIS Corporation Announces Fiscal 2009 Fourth Quarter and Full Year Results.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters